Similar to CTGF, it is IL11 and NOX4 that are regulated by PPP lysates that mediate the effects of TGF-β on cardiovascular and liver fibrosis [29,30], and acute kidney injury and pulmonary fibrosis [31,34], respectively. The gene discussed is CCN2; the disease is Hepatic fibrosis.